Lakefront Biotherapeutics | GLPG - PE Price to Earnings


Lakefront Biotherapeutics reported 2.68 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
argenx SE 33.43 2.1 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Biogen 29.15 5.92 Sep/2026
Genmab 16.04 1.05 Jun/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
GRIFOLS 13.04 1.66 Sep/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Incyte 54.54 40.08 Sep/2026
Merck 17.21 4.47 Jun/2026
Neurocrine Biosciences 83.17 61.07 Sep/2026
Novartis 19.17 3.24 Sep/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 22.34 3.38 Sep/2026
UCB 29.7 5.52 Dec/2025
Vertex Pharmaceuticals 29.35 1.3 Sep/2026